Epidemiology of multiple primary cancers

Methods in Molecular Biology

Volumn 471, Issue , 2009, Pages 85-105

  Soerjomataram, Isabelle ^a   Coebergh, Jan Willem ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b The Netherlands   (Netherlands)

Author keywords

Lifestyle factors; Multiple cancers; Risk factors; Survival

Indexed keywords

FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MULTIPLE CANCER; REVIEW; RISK FACTOR;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS, MULTIPLE PRIMARY; RISK FACTORS;

EID: 60349112669     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-416-2_5     Document Type: Review

References (117)

1. Fraumeni, J. F. J., Curtis, R., Edwards, B. K., Tucker, M. A. (2006) Introduction. Bethesda, MD: National Cancer Institute. pp. 1-7.
2. Sankila, R., Pukkala, E., Teppo, L. (1995) Risk of subsequent malignant neoplasms among 470,000 cancer patients in Finland, 1953-1991. Int J Cancer 60, 464-70.
3. Mariotto, A. B., Rowland, J. H., Ries, L. A., Scoppa, S., Feuer, E. J. (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev 16, 566-71.
4. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108.
5. Janssen-Heijnen, M. L., Houterman, S., Lemmens, V. E., Louwman, M. W., Maas, H. A., Coebergh, J. W. (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55, 231-40.
6. Soerjomataram, I., Louwman, M. W., Ribot, J. G., Roukema, J. A., Coebergh, J. W. (2007) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107, 309-330.
7. Howe, H. L. (2003) A review of the definition for multiple primary cancers in the United States. Workshop proceedings from December 4-6, 2002, in Princeton, New Jersey. Springfield (IL): North American Association of Central Cancer Registries.
8. Johnson, C. H., Adamo, M. (2007) SEER Program Coding and Staging Manual 2007. Bethesda, MD: National Cancer Institute.
9. Working Group Report. (2005) International rules for multiple primary cancers (ICD-0, third edition). Eur J Cancer Prev 14, 307-8.
10. Vriesema, J. L., Aben, K. K., Witjes, J. A., Kiemeney, L. A., Schalken, J. A. (2001) Superficial and metachronous invasive bladder carcinomas are clonally related. Int J Cancer 93, 699-702.
11. Aben, K. K., Witjes, J. A., van Dijck, J. A., Schalken, J. A., Verbeek, A. L., Kiemeney, L. A. (2000) Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin. Eur J Cancer 36, 2385-9.
12. Harari, P. M. (1998) Re: Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 90, 1571.
13. Smith, R. E., Bryant, J., DeCillis, A., Anderson, S. (2003) Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 21, 1195-204.
14. Huang, E., Buchholz, T. A., Meric, F., Krishnamurthy, S., Mirza, N. Q., Ames, F. C., Feig, B. W., Kuerer, H. M., Ross, M. I., Singletary, S. E., McNeese, M. D., Strom, E. A., Hunt, K. K. (2002) Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95, 2059-67.
15. Crocetti, E., Lecker, S., Buiatti, E., Storm, H. H. (1996) Problems related to the coding of multiple primary cancers. Eur J Cancer 32A, 1366-70.
16. Hotes, J. L., Ellison, L. F., Howe, H. L., Friesen, I., Kohler, B. (2004) Variation in breast cancer counts using SEER and IARC multiple primary coding rules. Cancer Causes Control 15, 185-91.
17. Scelo, G., Boffetta, P., Autier, P., Hemminki, K., Pukkala, E., Olsen, J. H., Weiderpass, E., Tracey, E., Brewster, D. H., McBride, M. L., Kliewer, E. V., Tonita, J. M., Pompe-Kirn, V., Chia, K. S., Jonasson, J. G., Martos, C., Giblin, M., Brennan, P. (2007) Associations between ocular melanoma and other primary cancers: an international population-based study. Int J Cancer 120, 152-9.
18. Scelo, G., Boffetta, P., Corbex, M., Chia, K. S., Hemminki, K., Friis, S., Pukkala, E., Weiderpass, E., McBride, M. L., Tracey, E., Brewster, D. H., Pompe-Kirn, V., Kliewer, E. V., Tonita, J. M., Martos, C., Jonasson, J. G., Brennan, P. (2007) Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control 18, 269-78.
19. Mellemkjaer, L., Friis, S., Olsen, J. H., Scelo, G., Hemminki, K., Tracey, E., Andersen, A., Brewster, D. H., Pukkala, E., McBride, M. L., Kliewer, E. V., Tonita, J. M., Kee-Seng, C., Pompe-Kirn, V., Martos, C., Jonasson, J. G., Boffetta, P., Brennan, P. (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118, 2285-92.
20. Tuohimaa, P., Pukkala, E., Scelo, G., Olsen, J. H., Brewster, D. H., Hemminki, K., Tracey, E., Weiderpass, E., Kliewer, E. V., Pompe-Kirn, V., McBride, M. L., Martos, C., Chia, K. S., Tonita, J. M., Jonasson, J. G., Boffetta, P., Brennan, P. (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 43, 1701-1712.
21. Grant, W. B. (2007) A meta-analysis of second cancers after a diagnosis of non-melanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol 103, 668-74.
22. de Vries, E., Soerjomataram, I., Houterman, S., Louwman, M. W., Coebergh, J. W. (2007) Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol 165, 966-72.
23. van Leeuwen, F. E., Travis, L. B. (2005) Second Cancers, 7 ed. Philadelphia. PA: Lippincott Williams and Wilkins. pp. 2575-602.
24. Travis, L. B. (2006) The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15, 2020-6.
25. Curtis, R., Ries, L. A. G. (2006) Methods. Bethesda, MD: National Cancer Institute. pp. 1-7.
26. Schoenberg, B. S., Myers, M. H. (1977) Statistical methods for studying multiple primary malignant neoplasms. Cancer 40, 1892-8.
27. Begg, C. B., Zhang, Z. F., Sun, M., Herr, H. W., Schantz, S. P. (1995) Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol 142, 653-65.
28. Cutler, S. J., Ederer, F. (1958) Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8, 699-712.
29. Gooley, T. A., Leisenring, W., Crowley, J., Storer, B. E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18, 695-706.
30. Yu, G. P., Schantz, S. P., Neugut, A. I., Zhang, Z. F. (2006) Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control 17, 411-20.
31. Yasui, Y., Liu, Y., Neglia, J. P., Friedman, D. L., Bhatia, S., Meadows, A. T., Diller, L. R., Mertens, A. C., Whitton, J., Robison, L. L. (2003) A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 158, 1108-13.
32. Travis, L. B. (2002) Therapy-associated solid tumors. Acta Oncol. 41, 323-33.
33. Largent, J. A., Capanu, M., Bernstein, L., Langholz, B., Mellemkjaer, L., Malone, K. E., Begg, C. B., Haile, R. W., Lynch, C. F., Anton-Culver, H., Wolitzer, A., Bernstein, J. L. (2007) Reproductive History and Risk of Second Primary Breast Cancer: the WECARE Study. Cancer Epidemiol Biomarkers Prev 16, 906-911.
34. Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., Figg, W. D., Gospodarowicz, M. K., Hall, E. J., Hisada, M., Inskip, P., Kleinerman, R., Little, J. B., Malkin, D., Ng, A. K., Offit, K., Pui, C. H., Robison, L. L., Rothman, N., Shields, P. G., Strong, L., Taniguchi, T., Tucker, M. A., Greene, M. H. (2006) Cancer survivorship - genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 98, 15-25.
35. Garber, J. E., Offit, K. (2005) Hereditary cancer predisposition syndromes. J Clin Oncol 23, 276-92.
36. Fearon, E. R. (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278, 1043-50.
37. Nagy, R., Sweet, K., Eng, C. (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23, 6445-70.
38. Hill, D. A., Gilbert, E., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., Van't Veer, M., Storm, H., Pukkala, E., Stovall, M., Curtis, R. E., Allan, J. M., Boice, J. D., Travis, L. B. (2005) Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 106, 3358-65.
39. Landgren, O., Pfeiffer, R. M., Stewart, L., Gridley, G., Mellemkjaer, L., Hemminki, K., Goldin, L. R., Travis, L. B. (2007) Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer 120, 1099-102.
40. Trentham-Dietz, A., Newcomb, P. A., Nichols, H. B., Hampton, J. M. (2007) Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat 105, 359-68.
41. Kmet, L. M., Cook, L. S., Weiss, N. S., Schwartz, S. M., White, E. (2003) Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat 79, 143-7.
42. Hisada, M., Garber, J. E., Fung, C. Y., Fraumeni, J. F., Jr., Li, F. P. (1998) Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 90, 606-11.
43. Hemminki, K., Ji, J., Forsti, A. (2007) Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res 67, 868-70.
44. Hemminki, K., Li, X. (2005) Familial risk for lung cancer by histology and age of onset: evidence for recessive inheritance. Exp Lung Res. 31, 205-15.
45. Soerjomataram, I., Louwman, W. J., de Vries, E., Lemmens, V. E., Klokman, W. J., Coebergh, J. W. (2005) Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 93, 91-5.
46. Soerjomataram, I., Louwman, W. J., Lemmens, V. E., de Vries, E., Klokman, W. J., Coebergh, J. W. (2005) Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer 41, 2331-7.
47. Raymond, J. S., Hogue, C. J. (2006) Multiple primary tumours in women following breast cancer, 1973-2000. Br J Cancer 94, 1745-50.
48. Metcalfe, K. A., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I. A., Foulkes, W. D., Warner, E., Olopade, O., Eisen, A., Weber, B., McLennan, J., Sun, P., Narod, S. A. (2005) The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 96, 222-6.
49. Metcalfe, K., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I., Warner, E., Olopade, O. I., Eisen, A., Weber, B., McLennan, J., Sun, P., Foulkes, W. D., Narod, S. A. (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22, 2328-35.
50. Lynch, H. T., Shaw, T. G., Lynch, J. F. (2004) Inherited predisposition to cancer: a historical overview. Am J Med Genet C Semin Med Genet 129, 5-22.
51. Meijers-Heijboer, H., Wijnen, J., Vasen, H., Wasielewski, M., Wagner, A., Hollestelle, A., Elstrodt, F., van den Bos, R., de Snoo, A., Fat, G. T., Brekelmans, C., Jagmohan, S., Franken, P., Verkuijlen, P., van den Ouweland, A., Chapman, P., Tops, C., Moslein, G., Burn, J., Lynch, H., Klijn, J., Fodde, R., Schutte, M. (2003) The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72, 1308-14.
52. Dong, C., Hemminki, K. (2001) Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer. 92, 883-7.
53. Balmain, A., Gray, J., Ponder, B. (2003) The genetics and genomics of cancer. Nat Genet 33 Suppl, 238-44.
54. Levi, F., Randimbison, L., Maspoli, M., Te, V. C., La Vecchia, C. (2007) Second neoplasms after oesophageal cancer. Int J Cancer 121, 694-7.
55. Shen, M., Boffetta, P., Olsen, J. H., Andersen, A., Hemminki, K., Pukkala, E., Tracey, E., Brewster, D. H., McBride, M. L., Pompe-Kirn, V., Kliewer, E. V., Tonita, J. M., Chia, K. S., Martos, C., Jonasson, J. G., Colin, D., Scelo, G., Brennan, P. (2006) A pooled analysis of second primary pancreatic cancer. Am J Epidemiol 163, 502-11.
56. Brown, L. M., McCarron, P., Freedman, D. M. (2006) New malignancies following cancer of the buccal cavity and pharynx. Bethesda, MD: National Cancer Institute. pp. 1-7.
57. Caporaso, N., Dodd, K. W., Tucker, M. A. (2006) New malignancies following cancer of the respiratory tract. Bethesda, MD: National Cancer Institute. 1-7.
58. Dikshit, R. P., Boffetta, P., Bouchardy, C., Merletti, F., Crosignani, P., Cuchi, T., Ardanaz, E., Brennan, P. (2005) Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 103, 2326-33.
59. Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., Linch, D. C. (2000) Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 18, 498-509.
60. Tucker, M. A., Murray, N., Shaw, E. G., Ettinger, D. S., Mabry, M., Huber, M. H., Feld, R., Shepherd, F. A., Johnson, D. H., Grant, S. C., Aisner, J., Johnson, B. E. (1997) Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst 89, 1782-8.
61. Khuri, F. R., Kim, E. S., Lee, J. J., Winn, R. J., Benner, S. E., Lippman, S. M., Fu, K. K., Cooper, J. S., Vokes, E. E., Chamberlain, R. M., Williams, B., Pajak, T. F., Goepfert, H., Hong, W. K. (2001) The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomark Prev 10, 823-9.
62. Gilbert, E. S., Stovall, M., Gospodarowicz, M., Van Leeuwen, F. E., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C. F., Curtis, R. E., Holowaty, E., Storm, H., Pukkala, E., van't Veer, M. B., Fraumeni, J. F., Boice, J. D., Jr., Clarke, E. A., Travis, L. B. (2003) Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 159, 161-73.
63. Travis, L. B., Gospodarowicz, M., Curtis, R. E., Clarke, E. A., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C. F., van Leeuwen, F. E., Holowaty, E., Storm, H., Glimelius, I., Pukkala, E., Stovall, M., Fraumeni, J. F., Jr., Boice, J. D., Jr., Gilbert, E. (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94, 182-92.
64. Do, K. A., Johnson, M. M., Lee, J. J., Wu, X. F., Dong, Q., Hong, W. K., Khuri, F. R., Spitz, M. R. (2004) Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101, 2837-42.
65. Pike, M. C., Pearce, C. L., Wu, A. H. (2004) Prevention of cancers of the breast, endometrium and ovary. Oncogene 23, 6379-91.
66. Samanic, C., Chow, W. H., Gridley, G., Jarvholm, B., Fraumeni, J. F., Jr. (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17, 901-9.
67. Mysliwiec, P. A., Cronin, K. A., Schatzkin, A. (2006) New Malignancies following cancer of the colon, rectum, and Anus. Bethesda, MD: National Cancer Institute. 1-7.
68. Dignam, J. J., Wieand, K., Johnson, K. A., Fisher, B., Xu, L., Mamounas, E. P. (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95, 1467-76.
69. Dignam, J. J., Wieand, K., Johnson, K. A., Raich, P., Anderson, S. J., Somkin, C., Wickerham, D. L. (2006) Effects of obesity and race on prognosis in lymph node-nega tive, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 97, 245-54.
70. Dignam, J. J., Polite, B. N., Yothers, G., Raich, P., Colangelo, L., O'Connell, M. J., Wolmark, N. (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98, 1647-54.
71. van Leeuwen, F. E., Klokman, W. J., Stovall, M., Dahler, E. C., van't Veer, M. B., Noordijk, E. M., Crommelin, M. A., Aleman, B. M., Broeks, A., Gospodarowicz, M., Travis, L. B., Russell, N. S. (2003) Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95, 971-80.
72. Swerdlow, A. J., Jones, M. E. (2005) Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 97, 375-84.
73. Kleinerman, R. A., Kosary, C., Hildesheim, A. (2006) New malignancies following cancer of the cervix uteri, vagina, and vulva. Bethesda, MD: National Cancer Institute. 1-7.
74. Hemminki, K., Dong, C., Vaittinen, P. (2000) Second primary cancer after in situ and invasive cervical cancer. Epidemiology 11, 457-61.
75. Levi, F., Te, V. C., Randimbison, L., La Vecchia, C. (2001) Second primary cancers after in situ and invasive cervical cancer. Epidemiology 12, 281-2.
76. Vinokurova, S., Wentzensen, N., Einenkel, J., Klaes, R., Ziegert, C., Melsheimer, P., Sartor, H., Horn, L. C., Hockel, M., von Knebel Doeberitz, M. (2005) Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst 97, 1816-21.
77. Brennan, P., Scelo, G., Hemminki, K., Mellemkjaer, L., Tracey, E., Andersen, A., Brewster, D. H., Pukkala, E., McBride, M. L., Kliewer, E. V., Tonita, J. M., Seow, A., Pompe-Kirn, V., Martos, C., Jonasson, J. G., Colin, D., Boffetta, P. (2005) Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 93, 159-66.
78. Dores, G. M., Cote, T. R., Travis, L. B. (2006) New malignancies following Hodgkin lymphoma, Non-Hodgkin Lymphoma, and Myeloma. Bethesda, MD: National Cancer Institute. 1-7.
79. Wang, C. C., Chen, M. L., Hsu, K. H., Lee, S. P., Chen, T. C., Chang, Y. S., Tsang, N. M., Hong, J. H. (2000) Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus. Int J Cancer 87, 228-31.
80. Schwartz, R. S. (2001) Immunodeficiency, immunosuppression, and susceptibility to neoplasms. J Natl Cancer Inst Monogr 5-9.
81. Clifford, G. M., Polesel, J., Rickenbach, M., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., Fisch, T., Bordoni, A., De Weck, D., Franceschi, S. (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97, 425-32.
82. Hemminki, K., Jiang, Y., Steineck, G. (2003) Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Eur J Cancer 39, 223-9.
83. Metayer, C., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., Joensuu, T., van Leeuwen, F. E., van't Veer, M. B., Curtis, R. E., Holowaty, E. J., Andersson, M., Wiklund, T., Gospodarowicz, M., Travis, L. B. (2000) Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18, 2435-43.
84. Allan, J. M., Travis, L. B. (2005) Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 5, 943-55.
85. Dores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., Andersson, M., Wiklund, T., Joensuu, T., van't Veer, M. B., Stovall, M., Gospodarowicz, M., Travis, L. B. (2002) Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20, 3484-94.
86. van Leeuwen, F. E., Klokman, W. J., Veer, M. B., Hagenbeek, A., Krol, A. D., Vetter, U. A., Schaapveld, M., van Heerde, P., Burgers, J. M., Somers, R., Aleman, B. M. (2000) Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18, 487-97.
87. Boice, J. D. Ionizing radiation. 3 ed. New York: Oxford University Press. 259-93.
88. Kleinerman, R. A., Tucker, M. A., Abramson, D. H., Seddon, J. M., Tarone, R. E., Fraumeni, J. F., Jr. (2007) Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 99, 24-31.
89. Wong, F. L., Boice, J. D., Jr., Abramson, D. H., Tarone, R. E., Kleinerman, R. A., Stovall, M., Goldman, M. B., Seddon, J. M., Tarbell, N., Fraumeni, J. F., Jr., Li, F. P. (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278, 1262-7.
90. Travis, L. B., Curtis, R. E., Glimelius, B., Holowaty, E. J., Van Leeuwen, F. E., Lynch, C. F., Hagenbeek, A., Stovall, M., Banks, P. M., Adami, J., et al. (1995) Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 87, 524-30.
91. Henderson, T. O., Whitton, J., Stovall, M., Mertens, A. C., Mitby, P., Friedman, D., Strong, L. C., Hammond, S., Neglia, J. P., Meadows, A. T., Robison, L., Diller, L. (2007) Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 99, 300-8.
92. Mudie, N. Y., Swerdlow, A. J., Higgins, C. D., Smith, P., Qiao, Z., Hancock, B. W., Hoskin, P. J., Linch, D. C. (2006) Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study. J Clin Oncol 24, 1568-74.
93. Garwicz, S., Anderson, H., Olsen, J. H., Dollner, H., Hertz, H., Jonmundsson, G., Langmark, F., Lanning, M., Moller, T., Sankila, R., Tulinius, H. (2000) Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 88, 672-8.
94. Travis, L. B., Hill, D. A., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., Van't Veer, M. B., Glimelius, I., Storm, H., Pukkala, E., Stovall, M., Curtis, R., Boice, J. D., Jr., Gilbert, E. (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290, 465-75.
95. Guerin, S., Guibout, C., Shamsaldin, A., Dondon, M. G., Diallo, I., Hawkins, M., Oberlin, O., Hartmann, O., Michon, J., Le Deley, M. C., de Vathaire, F. (2007) Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study. Int J Cancer 120, 96-102.
96. Rubino, C., de Vathaire, F., Shamsaldin, A., Labbe, M., Le, M. G. (2003) Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 89, 840-6.
97. (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365, 1687-717.
98. Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90, 1371-88.
99. Bergman, L., Beelen, M. L., Gallee, M. P., Hollema, H., Benraadt, J., van Leeuwen, F. E. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 356, 881-7.
100. Bernstein, J. L., Thompson, W. D., Risch, N., Holford, T. R. (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136, 925-36.
101. (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 351, 1451-67.
102. Teodorovic, I., Isabelle, M., Carbone, A., Passioukov, A., Lejeune, S., Jamine, D., Therasse, P., Gloghini, A., Dinjens, W. N., Lam, K. H., Oomen, M. H., Spatz, A., Ratcliffe, C., Knox, K., Mager, R., Kerr, D., Pezzella, F., van Damme, B., van de Vijver, M., van Boven, H., Morente, M. M., Alonso, S., Kerjaschki, D., Pammer, J., Lopez-Guerrero, J. A., Llombart Bosch, A., van Veen, E. B., Oosterhuis, J. W., Riegman, P. H. (2006) TuBaFrost 6: virtual microscopy in virtual tumour banking. Eur J Cancer 42, 3110-6.
103. Leong, P. P., Rezai, B., Koch, W. M., Reed, A., Eisele, D., Lee, D. J., Sidransky, D., Jen, J., Westra, W. H. (1998) Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 90, 972-7.
104. Blokx, W. A., Lesterhuis, J. J., Andriessen, M. P., Verdijk, M. A., Punt, K. J., Ligtenberg, M. J. (2007) CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma. Am J Surg Pathol 31, 637-41.
105. Geurts, T. W., Nederlof, P. M., van den Brekel, M. W., van't Veer, L. J., de Jong, D., Hart, A. A., van Zandwijk, N., Klomp, H., Balm, A. J., van Velthuysen, M. L. (2005) Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 11, 6608-14.
106. Travis, L. B., Hill, D., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Pukkala, E., Lynch, C. F., Pee, D., Smith, S. A., Van't Veer, M. B., Joensuu, T., Storm, H., Stovall, M., Boice, J. D., Jr., Gilbert, E., Gail, M. H. (2005) Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97, 1428-37.
107. Hijiya, N., Hudson, M. M., Lensing, S., Zacher, M., Onciu, M., Behm, F. G., Razzouk, B. I., Ribeiro, R. C., Rubnitz, J. E., Sandlund, J. T., Rivera, G. K., Evans, W. E., Relling, M. V., Pui, C. H. (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297, 1207-15.
108. Schonfeld, S. J., Gilbert, E. S., Dores, G. M., Lynch, C. F., Hodgson, D. C., Hall, P., Storm, H., Andersen, A., Pukkala, E., Holowaty, E., Kaijser, M., Andersson, M., Joensuu, H., Fossa, S. D., Allan, J. M., Travis, L. B. (2006) Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients. J Natl Cancer Inst 98, 215-8.
109. Howard, R. A., Gilbert, E. S., Chen, B. E., Hall, P., Storm, H., Pukkala, E., Langmark, F., Kaijser, M., Andersson, M., Joensuu, H., Fossa, S. D., Travis, L. B. (2007) Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res Treat 105, 359-368.
110. Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., Sturgeon, J., Stovall, M. (1999) Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med 340, 351-7.
111. Kaldor, J. M., Day, N. E., Pettersson, F., Clarke, E. A., Pedersen, D., Mehnert, W., Bell, J., Host, H., Prior, P., Karjalainen, S., et al. (1990) Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322, 1-6.
112. Robinson, D., Moller, H., Horwich, A. (2007) Mortality and incidence of second cancers following treatment for testicular cancer. Br J Cancer 96, 529-33.
113. Travis, L. B., Andersson, M., Gospodarowicz, M., van Leeuwen, F. E., Bergfeldt, K., Lynch, C. F., Curtis, R. E., Kohler, B. A., Wiklund, T., Storm, H., Holowaty, E., Hall, P., Pukkala, E., Sleijfer, D. T., Clarke, E. A., Boice, J. D., Jr., Stovall, M., Gilbert, E. (2000) Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst 92, 1165-71.
114. Le Deley, M. C., Leblanc, T., Shamsaldin, A., Raquin, M. A., Lacour, B., Sommelet, D., Chompret, A., Cayuela, J. M., Bayle, C., Bernheim, A., de Vathaire, F., Vassal, G., Hill, C. (2003) Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 21, 1074-81.
115. Neglia, J. P., Friedman, D. L., Yasui, Y., Mertens, A. C., Hammond, S., Stovall, M., Donaldson, S. S., Meadows, A. T., Robison, L. L. (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93, 618-29.
116. Kaldor, J. M., Day, N. E., Kittelmann, B., Pettersson, F., Langmark, F., Pedersen, D., Prior, P., Neal, F., Karjalainen, S., Bell, J., et al. (1995) Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 63, 1-6.
117. Hawkins, M. M., Wilson, L. M., Burton, H. S., Potok, M. H., Winter, D. L., Marsden, H. B., Stovall, M. A. (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88, 270-8.